Treatment of Blepharitis With Povidone-Iodine 1%

Treatment of Blepharitis With Povidone-Iodine 1% : a Randomized Controlled Trial

NCT05160623•Shaare Zedek Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Anterior Blepharitis

Interventions

Povidone-Iodine 1 % Topical Solution

Eyelid cleansing wipes

Locations

Israel

Locations (1)

Ophthalmology clinic, Shaare Zedek Medical Center

Jerusalem, Israel

Key Dates

Start Date

August 16, 2021

Primary Completion Date

December 1, 2022

Completion Date

December 1, 2022

Last Updated

December 16, 2021

Contacts

Elishai Assayag, MD

CONTACT

+972556612130 elishai.assayag@gmail.com

Sponsors

Lead Sponsor

Shaare Zedek Medical Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 16, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions